1993
DOI: 10.1126/science.7694365
|View full text |Cite
|
Sign up to set email alerts
|

Controlling Signal Transduction with Synthetic Ligands

Abstract: Dimerization and oligomerization are general biological control mechanisms contributing to the activation of cell membrane receptors, transcription factors, vesicle fusion proteins, and other classes of intra- and extracellular proteins. Cell permeable, synthetic ligands were devised that can be used to control the intracellular oligomerization of specific proteins. To demonstrate their utility, these ligands were used to induce intracellular oligomerization of cell surface receptors that lacked their transmem… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
670
1
13

Year Published

1995
1995
2011
2011

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 792 publications
(688 citation statements)
references
References 47 publications
4
670
1
13
Order By: Relevance
“…CIDs are low-molecular weight, cell-permeable, bivalent ligands that can mediate the clustering of two receptors. [4,116,[189][190][191] A key feature of CIDs is that they can oligomerize receptors fused to a specific ligand-binding protein ( Figure 6). In its first incarnation, this strategy utilized fusions to FKBP, a protein that binds to the immunosuppressant FK506.…”
Section: 1a Integrins-integrinsmentioning
confidence: 99%
“…CIDs are low-molecular weight, cell-permeable, bivalent ligands that can mediate the clustering of two receptors. [4,116,[189][190][191] A key feature of CIDs is that they can oligomerize receptors fused to a specific ligand-binding protein ( Figure 6). In its first incarnation, this strategy utilized fusions to FKBP, a protein that binds to the immunosuppressant FK506.…”
Section: 1a Integrins-integrinsmentioning
confidence: 99%
“…Marks et al made a noncovalent protein tag based on the small molecule immunosuppressant FK506 and its target FKBP12 [22], a system pioneered by the laboratory of Stuart Schreiber [23,24]. The 12 kDa human protein FKBP12 binds the natural ligand rapamycin with a K D of 0.2 nM and a synthetic ligand (SLF) with subnanomolar affinity [25].…”
Section: Noncovalent Protein Tagsmentioning
confidence: 99%
“…The emergence of small molecule-induced protein dimerization technology presents an intriguing avenue towards this goal. Systems for drug-directed protein dimerization were first described in the mid-1990s (Spencer et al, 1993(Spencer et al, , 1995Belshaw et al, 1996;Liberles et al, 1997), wherein target proteins are expressed as in-frame fusions with small, drugbinding tags (recently reviewed in Kley, 2004;Banaszynski and Wandless, 2006;Gestwicki and Marinec, 2007;Clackson, 2007). These appended domains have affinity for a divalent small molecule (e.g.…”
Section: Introductionmentioning
confidence: 99%